Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface
Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this techniq...
Gespeichert in:
Veröffentlicht in: | Annals of vascular surgery 2010-11, Vol.24 (8), p.1005-1014 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1014 |
---|---|
container_issue | 8 |
container_start_page | 1005 |
container_title | Annals of vascular surgery |
container_volume | 24 |
creator | Zanow, Juergen Kruger, Ulf Settmacher, Utz Scholz, Hans |
description | Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts. |
doi_str_mv | 10.1016/j.avsg.2010.03.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_762029815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0890509610001822</els_id><sourcerecordid>762029815</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</originalsourceid><addsrcrecordid>eNp9kU1rFTEUhoMo9lr9Ay4kO1dzPcl8JSCClLYKhRZuXYdMcuY215nJNckUZ-dPN8OtLly4Cpy8z0vyHELeMtgyYM2Hw1Y_xv2WQx5Auc2jZ2TDGlYXtaza52QDQkJRg2zOyKsYDwCMi0q8JGccBEDF5Yb8ug-o04hTor6ndxjcPug-0R0GP2rqJnr586gni5be-WFJmPL1MPvgMT0sA05Ir1cg0m7J0I85Nzk90CvXhQzvUA9u2q_d6QHp7ZwwnAC6m0OvDb4mL3o9RHzzdJ6Tb1eX9xdfipvb668Xn28KU7VNKrAta1tKUTadZVVlGlHXgnPei74pjYXWSqik5kIAgjUgula2He87aUuNLZbn5P2p9xh8fmVManTR4DDoCf0cVdtw4FKwOif5KWmCjzFgr47BjTosioFaxauDWsWrVbyCUuVRht491c_diPYv8sd0Dnw8BTB_8tFhUNE4nAxaF9AkZb37f_-nf3CTxTqjh--4YDz4OUxZn2IqcgVqt65-3TyDvPUsqvwNmsmqwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762029815</pqid></control><display><type>article</type><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</creator><creatorcontrib>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</creatorcontrib><description>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</description><identifier>ISSN: 0890-5096</identifier><identifier>EISSN: 1615-5947</identifier><identifier>DOI: 10.1016/j.avsg.2010.03.016</identifier><identifier>PMID: 20800429</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Blood Vessel Prosthesis ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - instrumentation ; Chi-Square Distribution ; Device Removal ; Female ; Fibrin Tissue Adhesive - chemistry ; Fibrin Tissue Adhesive - therapeutic use ; Germany ; Humans ; Hydrophobic and Hydrophilic Interactions ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Polytetrafluoroethylene - chemistry ; Porosity ; Prosthesis Design ; Reoperation ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Seroma - etiology ; Seroma - surgery ; Surgery ; Time Factors ; Treatment Outcome ; Vascular Patency</subject><ispartof>Annals of vascular surgery, 2010-11, Vol.24 (8), p.1005-1014</ispartof><rights>Annals of Vascular Surgery Inc.</rights><rights>2010 Annals of Vascular Surgery Inc.</rights><rights>Copyright © 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</citedby><cites>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.avsg.2010.03.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20800429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zanow, Juergen</creatorcontrib><creatorcontrib>Kruger, Ulf</creatorcontrib><creatorcontrib>Settmacher, Utz</creatorcontrib><creatorcontrib>Scholz, Hans</creatorcontrib><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><title>Annals of vascular surgery</title><addtitle>Ann Vasc Surg</addtitle><description>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Blood Vessel Prosthesis</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - instrumentation</subject><subject>Chi-Square Distribution</subject><subject>Device Removal</subject><subject>Female</subject><subject>Fibrin Tissue Adhesive - chemistry</subject><subject>Fibrin Tissue Adhesive - therapeutic use</subject><subject>Germany</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polytetrafluoroethylene - chemistry</subject><subject>Porosity</subject><subject>Prosthesis Design</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Seroma - etiology</subject><subject>Seroma - surgery</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><issn>0890-5096</issn><issn>1615-5947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1rFTEUhoMo9lr9Ay4kO1dzPcl8JSCClLYKhRZuXYdMcuY215nJNckUZ-dPN8OtLly4Cpy8z0vyHELeMtgyYM2Hw1Y_xv2WQx5Auc2jZ2TDGlYXtaza52QDQkJRg2zOyKsYDwCMi0q8JGccBEDF5Yb8ug-o04hTor6ndxjcPug-0R0GP2rqJnr586gni5be-WFJmPL1MPvgMT0sA05Ir1cg0m7J0I85Nzk90CvXhQzvUA9u2q_d6QHp7ZwwnAC6m0OvDb4mL3o9RHzzdJ6Tb1eX9xdfipvb668Xn28KU7VNKrAta1tKUTadZVVlGlHXgnPei74pjYXWSqik5kIAgjUgula2He87aUuNLZbn5P2p9xh8fmVManTR4DDoCf0cVdtw4FKwOif5KWmCjzFgr47BjTosioFaxauDWsWrVbyCUuVRht491c_diPYv8sd0Dnw8BTB_8tFhUNE4nAxaF9AkZb37f_-nf3CTxTqjh--4YDz4OUxZn2IqcgVqt65-3TyDvPUsqvwNmsmqwA</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Zanow, Juergen</creator><creator>Kruger, Ulf</creator><creator>Settmacher, Utz</creator><creator>Scholz, Hans</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101101</creationdate><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><author>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Blood Vessel Prosthesis</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - instrumentation</topic><topic>Chi-Square Distribution</topic><topic>Device Removal</topic><topic>Female</topic><topic>Fibrin Tissue Adhesive - chemistry</topic><topic>Fibrin Tissue Adhesive - therapeutic use</topic><topic>Germany</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polytetrafluoroethylene - chemistry</topic><topic>Porosity</topic><topic>Prosthesis Design</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Seroma - etiology</topic><topic>Seroma - surgery</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zanow, Juergen</creatorcontrib><creatorcontrib>Kruger, Ulf</creatorcontrib><creatorcontrib>Settmacher, Utz</creatorcontrib><creatorcontrib>Scholz, Hans</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zanow, Juergen</au><au>Kruger, Ulf</au><au>Settmacher, Utz</au><au>Scholz, Hans</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</atitle><jtitle>Annals of vascular surgery</jtitle><addtitle>Ann Vasc Surg</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>24</volume><issue>8</issue><spage>1005</spage><epage>1014</epage><pages>1005-1014</pages><issn>0890-5096</issn><eissn>1615-5947</eissn><abstract>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>20800429</pmid><doi>10.1016/j.avsg.2010.03.016</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0890-5096 |
ispartof | Annals of vascular surgery, 2010-11, Vol.24 (8), p.1005-1014 |
issn | 0890-5096 1615-5947 |
language | eng |
recordid | cdi_proquest_miscellaneous_762029815 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Aged Aged, 80 and over Blood Vessel Prosthesis Blood Vessel Prosthesis Implantation - adverse effects Blood Vessel Prosthesis Implantation - instrumentation Chi-Square Distribution Device Removal Female Fibrin Tissue Adhesive - chemistry Fibrin Tissue Adhesive - therapeutic use Germany Humans Hydrophobic and Hydrophilic Interactions Kaplan-Meier Estimate Male Middle Aged Polytetrafluoroethylene - chemistry Porosity Prosthesis Design Reoperation Retrospective Studies Risk Assessment Risk Factors Seroma - etiology Seroma - surgery Surgery Time Factors Treatment Outcome Vascular Patency |
title | Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Perigraft%20Seroma%20in%20Expanded%20Polytetrafluoroethylene%20Grafts%20by%20Sequential%20Fibrin%20Sealing%20of%20the%20Outer%20Graft%20Surface&rft.jtitle=Annals%20of%20vascular%20surgery&rft.au=Zanow,%20Juergen&rft.date=2010-11-01&rft.volume=24&rft.issue=8&rft.spage=1005&rft.epage=1014&rft.pages=1005-1014&rft.issn=0890-5096&rft.eissn=1615-5947&rft_id=info:doi/10.1016/j.avsg.2010.03.016&rft_dat=%3Cproquest_cross%3E762029815%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762029815&rft_id=info:pmid/20800429&rft_els_id=1_s2_0_S0890509610001822&rfr_iscdi=true |